Clinical Trial: A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082192) titled 'A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)' on July 11.

Brief Summary: The goal of this clinical trial is to learn if drug CB03-154 works to treat ALS in adults. It will also learn about the safety of drug CB03-154.

The main questions it aims to answer are:

* Does drug CB03-154 have an effect on delaying disease progression, improving function, and prolonging survival in adult ALS patients?

* What medical problems do patients have when taking drug CB03-154? Researchers will compare drug CB03-154 to a placebo (a look-alike substance that con...